DrugPatentWatch Database Preview
TRIESENCE Drug Profile
Which patents cover Triesence, and what generic alternatives are available?
Triesence is a drug marketed by Novartis Pharms Corp and is included in one NDA. There are three patents protecting this drug.
This drug has twenty-three patent family members in nineteen countries.
The generic ingredient in TRIESENCE is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Eighty-three suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
Summary for TRIESENCE
International Patents: | 23 |
US Patents: | 3 |
Applicants: | 1 |
NDAs: | 1 |
Suppliers / Packagers: | 1 |
Bulk Api Vendors: | 61 |
Clinical Trials: | 4 |
Patent Applications: | 4,484 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for TRIESENCE |
DailyMed Link: | TRIESENCE at DailyMed |

Pharmacology for TRIESENCE
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for TRIESENCE
US Patents and Regulatory Information for TRIESENCE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis Pharms Corp | TRIESENCE | triamcinolone acetonide | INJECTABLE;INTRAVITREAL | 022048-001 | Nov 29, 2007 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
Novartis Pharms Corp | TRIESENCE | triamcinolone acetonide | INJECTABLE;INTRAVITREAL | 022048-001 | Nov 29, 2007 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
Novartis Pharms Corp | TRIESENCE | triamcinolone acetonide | INJECTABLE;INTRAVITREAL | 022048-001 | Nov 29, 2007 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for TRIESENCE
Country | Document Number | Estimated Expiration |
---|---|---|
Mexico | 2010009974 | ➤ Sign Up |
South Africa | 201005839 | ➤ Sign Up |
Brazil | PI0909630 | ➤ Sign Up |
South Korea | 101555293 | ➤ Sign Up |
China | 101959519 | ➤ Sign Up |
Taiwan | 200940071 | ➤ Sign Up |
Country | Document Number | Estimated Expiration |